Advanced Medical Solutions Group - AMS Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 300
  • Forecasted Upside: 41.84%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
GBX 211.50
▼ -1.5 (-0.70%)

This chart shows the closing price for AMS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Advanced Medical Solutions Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AMS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AMS

Analyst Price Target is GBX 300
▲ +41.84% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Advanced Medical Solutions Group in the last 3 months. The average price target is GBX 300, with a high forecast of GBX 300 and a low forecast of GBX 300. The average price target represents a 41.84% upside from the last price of GBX 211.50.

This chart shows the closing price for AMS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 contributing investment analysts is to buy stock in Advanced Medical Solutions Group. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/28/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/26/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/27/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/25/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/23/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/21/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/21/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/21/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/27/2024Berenberg BankBoost TargetBuyGBX 290 ➝ GBX 300
9/20/2023Berenberg BankReiterated RatingBuyGBX 290
9/4/2023Berenberg BankLower TargetBuyGBX 310 ➝ GBX 290
3/15/2023Liberum CapitalDowngradeHoldGBX 296
3/15/2023Berenberg BankReiterated RatingBuyGBX 310
1/27/2020Panmure GordonReiterated RatingHold
5/30/2019Numis SecuritiesUpgradeAdd
(Data available from 5/22/2019 forward)

News Sentiment Rating

1.00 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/24/2023
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/23/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/23/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/22/2024
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/21/2024
  • 4 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/22/2024
  • 2 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/21/2024
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/21/2024

Current Sentiment

  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Advanced Medical Solutions Group logo
Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand brand; sutures and collagen-based products for the surgical and dental markets under the RESORBA brand; collagens; and hernia mesh fixation device that allows for the accurate laparoscopic internal application of its cyanoacrylate adhesive to attach hernia meshes under the LiquiBandFix8 brand, as well as internal sealants under the Seal-G/Seal-G MIST brand. The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobials, and hydrocolloids, as well as wound care products under the ActivHeal brand, as well as under white-label. Advanced Medical Solutions Group plc was founded in 1991 and is headquartered in Winsford, the United Kingdom.
Read More

Today's Range

Now: GBX 211.50
Low: 210
High: 213.88

50 Day Range

MA: GBX 192.86
Low: 179.20
High: 216.50

52 Week Range

Now: GBX 211.50
Low: 165.60
High: 261

Volume

52,197 shs

Average Volume

438,195 shs

Market Capitalization

£453.05 million

P/E Ratio

3,021.43

Dividend Yield

1.12%

Beta

0.57

Frequently Asked Questions

What sell-side analysts currently cover shares of Advanced Medical Solutions Group?

The following equities research analysts have issued reports on Advanced Medical Solutions Group in the last twelve months: Berenberg Bank.
View the latest analyst ratings for AMS.

What is the current price target for Advanced Medical Solutions Group?

1 Wall Street analysts have set twelve-month price targets for Advanced Medical Solutions Group in the last year. Their average twelve-month price target is GBX 300, suggesting a possible upside of 40.8%. Berenberg Bank has the highest price target set, predicting AMS will reach GBX 300 in the next twelve months. Berenberg Bank has the lowest price target set, forecasting a price of GBX 300 for Advanced Medical Solutions Group in the next year.
View the latest price targets for AMS.

What is the current consensus analyst rating for Advanced Medical Solutions Group?

Advanced Medical Solutions Group currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AMS will outperform the market and that investors should add to their positions of Advanced Medical Solutions Group.
View the latest ratings for AMS.

What other companies compete with Advanced Medical Solutions Group?

How do I contact Advanced Medical Solutions Group's investor relations team?

Advanced Medical Solutions Group's physical mailing address is Unit A, Premier Park, 33 Road One, WINSFORD, CW7 3RT, United Kingdom. The company's listed phone number is +44-1606-863500. The official website for Advanced Medical Solutions Group is www.admedsol.com. Learn More about contacing Advanced Medical Solutions Group investor relations.